Health
Nivolumab and Chemotherapy for Mesothelioma is Focus of New Trial – Surviving Mesothelioma
Researchers in Germany are recruiting patients for a trial of nivolumab and chemotherapy for pleural mesothelioma patients after surgery.
Researchers in Germany are recruiting patients for a trial of nivolumab and chemotherapy for pleural mesothelioma patients who have had surgery.
Nivolumab (Opdivo) is an immunotherapy drug similar to pembrolizumab (Keytruda). It blocks a protein that helps mesothelioma cells hide from the immune system. Nivolumab is most often used for patients with non-small cell lung cancer.
The multicenter German study will test if a combination of nivolumab and chemotherapy can help keep tumors from growing…
-
Noosa News17 hours agoBusiness expo sparks inspiration and connection
-
Noosa News17 hours agoSee inside the hidden suburbs where Queensland investors really live
-
Noosa News16 hours agoThe best new books released in August, from Toni Jordan, Rhett Davis and more
-
Business15 hours agoWhy it’s time to buy Domino’s, Flight Centre, and WiseTech shares